The generic name for the drug is semaglutide, and Novo Nordisk started making new forms of the drugs that are specifically for people who want to lose weight
Quick Answer: No, commercially available GLP-1 patches have not been proven effective and lack FDA approval for weight loss or diabetes management
Cost Using active base ingredients allows Henry to keep costs down and provide reasonably priced service for people without insurance
In a study of 3,731 patients assigned to take either liraglutide or placebo, 63.2% of patients taking liraglutide lost at least 5% of their body weight and 33.1% of patients lost at least 10% of their body weight
Who developed Retatrutide
Erick Turner, who used to work for the FDA but is now at Oregon Health and Science University, said the fact many patients stopped suffering suicidal thoughts when they came off the drug made it 'harder to explain away the suicidality'